Spinal muscular atrophy treatment in utero.

Nat Rev Neurol

Nature Reviews Neurology, .

Published: March 2025

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41582-025-01076-9DOI Listing

Publication Analysis

Top Keywords

spinal muscular
4
muscular atrophy
4
atrophy treatment
4
treatment utero
4
spinal
1
atrophy
1
treatment
1
utero
1

Similar Publications

Purpose: This study aimed to determine the feasibility and clinical utility of the Diego™ for people with a cervical spinal cord injury (CSI) in an acute spinal ward.

Materials And Methods: A mixed methods study included prospective measurement of outcomes and qualitative interviews with participants and health professionals. A 22 day (4.

View Article and Find Full Text PDF

Aim: To explore the relationship between household poverty, inequality, and disability among children in rural Bangladesh.

Method: This was a matched case-control study in Shahjadpur, northern Sirajganj, Bangladesh. Children aged younger than 18 years with disabilities (i.

View Article and Find Full Text PDF

Aim: To report on treatment outcomes in adult patients with spinal muscular atrophy type 3 (SMA3) who had their nusinersen treatment initiated in adulthood.

Methods: The study enrolled 11 adults treated with nusinersen for SMA3 at the Croatian National Referral Centre for Neuromuscular Disorders from 2019 to 2022. We prospectively collected validated SMA outcome measures: Revised Hammersmith score (RHS), Revised Upper Limb Module, and 6-minute walk test (6MWT) as motor function outcomes and the Individualized Neuromuscular Quality of Life questionnaire.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!